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Manuscript
Chronic heart failure increases the risk of atrial fibrillation (AF), with the prevalence 
of AF paralleling the severity of heart failure.
1
 Factors which underlie this increased 
susceptibility to AF may include electrical, structural and neurohumoral changes.
2
 In 
AF it is recognised that atrial electrophysiological remodelling occurs and contributes 
to the perpetuation of the arrhythmia, most notably the decrease of effective refractory 
period (ERP) which predisposes to re-entry by shortening the wavelength. Does heart 
failure cause similar changes in atrial electrophysiology that predispose to the 
arrhythmia? 
 
An extensively studied dog model, in which heart failure was induced by rapid 
ventricular pacing, has suggested not: atrial electrophysiological changes were either 
absent, or were in the opposite direction, with prolongation of the action potential 
duration (APD).
3 4 
Susceptibility to induced AF was increased, but this was more 
related to structural changes, in particular increased fibrosis,
5
 than 
electrophysiological properties. By contrast, our recent study of human right atrial 
isolated myocytes
6
 found that left ventricular (LV) systolic dysfunction was 
associated with electrophysiological changes – decreased APD and shortened 
refractoriness - which would predispose to AF, contrary to the findings in the dog 
model. 
 
The study by Sridhar et al in this issue
7
 sheds some light on this discrepancy, 
indicating that the key factor may be the duration of heart failure. The main 
methodological difference in the dog model used in this study was the duration of 
ventricular tachypacing – at least 4 months, compared to a maximum of 6 weeks in 
previous studies. In contrast to the studies with short-term heart failure, this study of 
chronic heart failure found that the LV dysfunction was not fully reversible, the 
induced AF was sustained rather than self-terminating, and there was atrial 
electrophysiological remodelling with shortening of left atrial myocyte APD (both at 
50% and 90% repolarisation) and of right atrial ERP in vivo. They also found 
increased fibrosis similar to that described with shorter duration heart failure, 
suggesting that the progressive changes were electrophysiological rather than 
structural. This study provides a new insight into the association between chronic 
heart failure and AF but also raises a number of questions. 
 
What are the ionic mechanisms underlying the shortening of APD and ERP with 
chronic heart failure? An increase in Ito was found,
7
 consistent with the observed 
shortening of early repolarisation, although it might be expected to have less influence 
on late repolarisation or ERP. However, a mathematical model of a canine atrial cell 
showed that such an increase in Ito would shorten both early and late repolarisation.
8
 
Alternatively, the reported decreases in potassium currents (IKur, IKs, IK1) would tend 
to oppose this effect. There was no change in ICaL, although the shortened early APD 
due to the Ito increase might decrease the duration of ICaL, and thus shorten late 
repolarisation.
7
 However, this would also affect other currents, such as the delayed 
rectifiers, which might be activated less strongly, opposing late APD-shortening. 
 
Why did Ito increase, and not decrease as found in numerous models of atrial 
pathology, including short term heart failure in dogs
3
, and chronic AF
9
 or LV systolic 
dysfunction
6
 in humans? There was no change in Kv4.3 protein, the a-subunit which 
carries Ito, but the Kv channel interacting protein 2 (KChIP2), which affects Kv4 
surface expression and functional properties, was increased.
7
 This would be consistent 
with the observed Ito increase, as well as the IKs decrease, since Ito was decreased and 
IKs increased in mice in which the gene encoding KChIP2 was deleted.
10
 The role of 
increased oxidative stress was investigated, and an anti-oxidant prevented the Ito 
increase - but did not reverse the shortening of terminal repolarisation in chronic heart 
failure.
7
  
 
What happens to atrial intracellular calcium handling with chronic heart failure? In 
the short-term heart failure model, after 2-weeks of ventricular tachypacing there was 
APD prolongation and cellular calcium overload with resultant triggered or 
spontaneous arrhythmic activity.
11
 This is in contrast to the chronic heart failure 
model where the shortened action potential resulted in reduced ICaL and thus less 
calcium entry.
7
 However, the changes in calcium handling and related regulatory 
proteins observed with short-term heart failure
11
 have yet to be studied in chronic 
heart failure. 
 
What are the mechanisms by which LV failure induces electrophysiological changes 
in the atria? For the left atrium, this could include direct mechanical effects, such as 
stretch, but right atrial changes induced by LV failure suggest a humoral mediator, in 
line with the finding of increased atrial angiotensin-1 receptor expression.
7
 Clinical 
studies have shown reduced AF in patients treated with ACE inhibitors or angiotensin 
receptor blockers, with or without heart failure.
12
 In the short-term heart failure dog 
model, enalapril reduced the duration of induced AF, but by attenuating structural, 
rather than electrical, remodelling with reduction in atrial fibrosis.
13
  
 
There are limitations to the study by Sridhar et al, and unanswered questions remain. 
It is not known whether the shortening in atrial ERP and APD in their model would be 
preceded by increases, since shorter periods of heart failure were not studied. It 
cannot be excluded that aspects of the model other than duration of pacing may differ 
between this and the earlier studies. The underlying changes in ionic currents 
(increased Ito; decreased IKur, IKs, IK1; no change in ICaL)
7
 were different from those in 
human atrial myocytes (decreased Ito; no change in ICaL, IK1, Isus).
6
 Other findings in 
humans with LV dysfunction are not consistent (see review
2
) with reports of 
increased, or unchanged, APD90 and a single study finding increased Ito. An in vivo 
study of atrial electrophysiology in patients with heart failure found a modest increase 
of ERP.
14
  
 
Much work remains to be done, and the present study indicates the complexity 
underlying the association between heart failure and AF. Taken together with the 
previous studies of shorter duration heart failure, it suggests that there may be 
different electrophysiological mechanisms predisposing to AF depending on the 
duration of heart failure – altered substrate predisposing to re-entry with chronic heart 
failure in contrast to the increase in triggers due to calcium overload in acute heart 
failure. 
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